tiprankstipranks
Trending News
More News >
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market

ADC Therapeutics (ADCT) Income Statement

Compare
342 Followers

ADC Therapeutics Income Statement

Last quarter (Q3 2024), ADC Therapeutics's total revenue was $18.46M, an increase of 27.40% from the same quarter last year. In Q3, ADC Therapeutics's net income was $-43.97M. See ADC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 69.28M$ 69.56M$ 209.91M$ 33.92M$ 0.00
Gross Profit
$ 63.33M$ 67.03M$ 205.33M$ 32.52M$ -1.97M
Operating Expenses
$ 107.51M$ 233.01M$ 328.96M$ 294.24M$ 219.26M
Depreciation and Amortization
$ 0.00$ 3.27M$ 2.39M$ 2.63M$ 1.97M
EBITDA
$ -130.65M$ -146.76M$ -108.06M$ -223.72M$ -219.26M
Operating Income
$ -130.65M$ -165.99M$ -123.63M$ -261.72M$ -219.26M
Other Income/Expenses
$ -25.48M$ -29.43M$ -33.56M$ 10.21M$ -26.70M
Pretax Income
$ -156.14M$ -195.42M$ -154.66M$ -251.50M$ -245.96M
Net Income
$ -157.85M$ -240.05M$ -155.80M$ -230.03M$ -246.29M
Per Share Metrics
Basic EPS
$ -1.62$ -2.94$ -1.99$ -3.00$ -3.77
Diluted EPS
$ -1.62$ -2.94$ -1.99$ -3.00$ -3.77
Weighted Average Shares Outstanding
97.16M 81.71M 78.15M 76.75M 65.41M
Weighted Average Shares Outstanding (Diluted)
97.16M 81.71M 78.15M 76.75M 65.41M
Currency in USD

ADC Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis